Condition
Multiple Myleoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Multiple Myleoma clinical trials that are recruiting, at sites in 9 countries (most in Bosnia and Herzegovina (1), Bulgaria (1), Croatia (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 9Countries
All recruiting trials (2)
-
GR1803 injection for patients with relapsed/refractory multiple myeloma
This study is testing if the GR1803 injection can help people with relapsed or refractory multiple myeloma feel better and manage their disease.
-
Evaluating XEMBIFY® with standard treatment to prevent infections in patients with certain blood cancers
This study is testing if adding XEMBIFY® to standard treatment can help prevent serious infections in adults with certain blood cancers.
Related topics
Quick answers
How many Multiple Myleoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Bosnia and Herzegovina (1 trial), Bulgaria (1 trial), Croatia (1 trial), Hungary (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.